UBS Raises Price Target on MetLife (MET) Following Investor Day
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
UBS reiterated a Neutral rating on MetLife (NYSE: MET), and raised the price target to $54.00 (from $48.00), following the company's investor day. Management identified several growth areas including Group benefits, Latin America, and P&C and anticipates its international earnings to grow in proportion. The company also anticipates a near-term ROE spread over risk-free rate of 8%, rising to 9-10% over time. The Board has authorized a $3bn share repurchases program to be completed by the end of 2017.
Analyst Brian Meredith commented, "MET hosted its Investor day this morning, whereby management discussed the strategy, opportunities and challenges. Management identifies several growth areas including Group benefits, Latin America, and P&C and anticipates its international earnings to grow in proportion. It also intends to maximize free cash flow and profitability at MetLife Holdings, while winding down the operation. MET notes all new business require IRR above hurdle rate and short payback period. After separation of Brighthouse (BHF), management estimates an average free cash flow ratio of 65-75% for 2017 and 2018 and continues to target an $800mm net annual savings by 2020."
Shares of MetLife closed at $53.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Raises Price Target on Francesca's (FRAN) Following 3Q Report
- Oppenheimer Raises Price Target on Bob Evans Farms (BOBE) Following 2Q EPS Beat
- Western Digital (WDC) PT Raised to $100 at Brean Capital on Way to $120
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change
Related EntitiesUBS, Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!